Sygnia Itrix Health Innovation Actively Managed ETF

Sygnia Itrix Health Innovation Actively Managed ETF is offered by Sygnia, a leading player in the field of passive investments.

The total expense ratio of Sygnia Itrix Health Innovation Actively Managed ETF is 0.53%, which means that investors pay 53 ZAR per 10,000 ZAR in investment capital annually.

The ETF is listed in ZAR.

European investors may incur additional costs for currency exchange and transaction fees.

No, Sygnia Itrix Health Innovation Actively Managed ETF does not comply with the EU UCITS investor protection directives.

The P/E ratio of Sygnia Itrix Health Innovation Actively Managed ETF is 20.96.

Sygnia Itrix Health Innovation Actively Managed ETF is domiciled in ZA.

The fund was launched on 8/6/2021.

The Sygnia Itrix Health Innovation Actively Managed ETF mainly invests in Healthcare companies.

The NAV of Sygnia Itrix Health Innovation Actively Managed ETF amounts to 30.28 M ZAR.

The price-to-book ratio is 4.3.

Investments can be made through brokers or financial institutions that provide access to trading ETFs.

The ETF is traded on the stock exchange, similar to stocks.

Yes, the ETF can be held in a regular securities account.

The ETF is suitable for both short-term and long-term investment strategies, depending on the investor's goals.

The ETF is valued on a daily stock exchange basis.

Information on dividends should be requested from the provider's website or your broker.

The risks include market fluctuations, currency risks, and the risk associated with smaller companies.

The ETF is obligated to report regularly and transparently on its investments.

The performance can be viewed on Eulerpool or directly on the provider's website.

Further information can be found on the official website of the provider.